SE7714110L - Forfarande for framstellning av karboxylsyraderivat - Google Patents

Forfarande for framstellning av karboxylsyraderivat

Info

Publication number
SE7714110L
SE7714110L SE7714110A SE7714110A SE7714110L SE 7714110 L SE7714110 L SE 7714110L SE 7714110 A SE7714110 A SE 7714110A SE 7714110 A SE7714110 A SE 7714110A SE 7714110 L SE7714110 L SE 7714110L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
carboxylic acid
acid derivatives
derivatives
Prior art date
Application number
SE7714110A
Other languages
English (en)
Other versions
SE436740B (sv
Inventor
M Bayssat
F Sautel
J-C Depin
A Betbeder-Matibet
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of SE7714110L publication Critical patent/SE7714110L/sv
Publication of SE436740B publication Critical patent/SE436740B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7714110A 1976-12-14 1977-12-13 Forfarande for framstellning av derivat av 5-bensoyl-indan-2-karboxylsyra eller salter eller alkylestrar derav SE436740B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7637574A FR2374032A2 (fr) 1976-12-14 1976-12-14 Nouveaux acides carboxyliques derives de l'indane

Publications (2)

Publication Number Publication Date
SE7714110L true SE7714110L (sv) 1978-06-15
SE436740B SE436740B (sv) 1985-01-21

Family

ID=9181028

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714110A SE436740B (sv) 1976-12-14 1977-12-13 Forfarande for framstellning av derivat av 5-bensoyl-indan-2-karboxylsyra eller salter eller alkylestrar derav

Country Status (21)

Country Link
JP (1) JPS5373548A (sv)
AT (1) AT355559B (sv)
AU (1) AU515268B2 (sv)
BE (1) BE861826R (sv)
CA (1) CA1088554A (sv)
CH (1) CH627728A5 (sv)
DD (1) DD133323A6 (sv)
DE (1) DE2753315A1 (sv)
DK (1) DK144640C (sv)
ES (1) ES465056A2 (sv)
FR (1) FR2374032A2 (sv)
GB (1) GB1584298A (sv)
HU (1) HU177226B (sv)
IE (1) IE46013B1 (sv)
IL (2) IL60598A0 (sv)
MX (1) MX4954E (sv)
NL (1) NL7713876A (sv)
NO (1) NO774285L (sv)
SE (1) SE436740B (sv)
SU (1) SU799646A3 (sv)
ZA (1) ZA777438B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2582674B1 (en) * 2010-06-16 2014-10-01 Cymabay Therapeutics, Inc. Gpr120 receptor agonists and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4980053A (sv) * 1972-12-05 1974-08-02
JPS5838416B2 (ja) * 1974-05-31 1983-08-23 武田薬品工業株式会社 カンジヨウカゴウブツノセイゾウホウ
JPS5335944B2 (sv) * 1974-05-21 1978-09-29

Also Published As

Publication number Publication date
DK144640C (da) 1982-10-04
MX4954E (es) 1983-01-13
NO774285L (no) 1978-06-15
DE2753315A1 (de) 1978-06-15
NL7713876A (nl) 1978-06-16
SE436740B (sv) 1985-01-21
ZA777438B (en) 1979-05-30
DK144640B (da) 1982-04-26
DK554677A (da) 1978-06-15
FR2374032B2 (sv) 1979-03-30
FR2374032A2 (fr) 1978-07-13
IL60598A0 (en) 1980-09-16
CA1088554A (fr) 1980-10-28
CH627728A5 (en) 1982-01-29
BE861826R (fr) 1978-06-14
DD133323A6 (de) 1978-12-27
IL60599A0 (en) 1980-09-16
AU515268B2 (en) 1981-03-26
SU799646A3 (ru) 1981-01-23
AU3153077A (en) 1979-06-21
AT355559B (de) 1980-03-10
IE46013B1 (en) 1983-01-26
GB1584298A (en) 1981-02-11
IE46013L (en) 1978-06-14
ES465056A2 (es) 1979-01-16
HU177226B (en) 1981-08-28
JPS5373548A (en) 1978-06-30
ATA892577A (de) 1979-08-15

Similar Documents

Publication Publication Date Title
TR19755A (tr) Tereftalik asidin hazirlanmasina mahsus usul
SE429961B (sv) Forfarande for framstellning av mjolksyra
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
SE7613565L (sv) Forfarande for framstellning av fusidinsyraderivat
SE7803853L (sv) Forfarande for framstellning av estrar av oxalsyra
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE440080B (sv) Forfarande for framstellning av klavulansyraderivat
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE421787B (sv) Forfarande for framstellning av kvadratsyra
NO773622L (no) Fremgangsmaate til fremstilling av tereftalsyre
NO152451C (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE436744B (sv) Forfarande for framstellning av prostacyklinderivat
SE7601151L (sv) Forfarande for framstellning av cefemkarboxylsyror
SE434743B (sv) Forfarande for framstellning av (2-pyrimidinyl-tio)-alkansyraamider
SE7607322L (sv) Forfarande for framstellning av 16-etrar av fusidinsyraderivat
NO141716C (no) Fremgangsmaate for fremstilling av tiokarbaminsyreestere
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE7714110L (sv) Forfarande for framstellning av karboxylsyraderivat
SE427037B (sv) Forfarande for framstellning av deoxiklavulansyra
DK9477A (da) Fremgangsmade til fremstilling af karboxylsyrederivater af indan
SE7714765L (sv) Forfarande for framstellning av omega-aryl-13-prostyn-syraderivat
SE7706725L (sv) Forfarande for framstellning av cefemderivat